Importance of Evidence-Based Medicine Presented in New Issue Brief Available
PHILADELPHIA, April 25, 2013
PHILADELPHIA, April 25, 2013 /PRNewswire/ --
Report identifies potential impact of evidence-based medicine in meeting
today's healthcare challenges
Elsevier , a world-leading provider of scientific, technical and medical
information products and services, today announced the availability of the
first in a series of issue briefs on evidence-based medicine (EBM). The issue
brief - "Building a Business Case for Evidence-Based Medicine" - reveals the
urgent need for EBM, as identified in a roundtable discussion of healthcare
industry thought leaders at the CMIO Leadership Forum: Transforming Healthcare
Through Evidence-based Medicine , last fall in Chicago.
The roundtable discussion, which featured five physicians representing
hospital and healthcare technology CMIOs, research directors and clinical
professors, was convened by the developers of ClinicalKey, Elsevier's clinical
insight engine designed to help physicians quickly locate accurate answers to
their clinical questions. The issue brief, based on the roundtable, emphasizes
the need for a business case for EBM as a central necessity to enhancing the
American healthcare system. According to findings highlighted within the
brief, making the business case for EBM will not be attributed to a single
event or destination, but will become more of a process or journey.
"By relying on fast, comprehensive, point-of-care clinical reference tools,
clinicians will be better able to pursue the 'shared practice' approach so
vital to the patient-centered medical home and accountable care," said David
Goldmann, M.D., Vice President and Chief Medical Quality Assurance Officer at
Elsevier. "EBM solutions have the potential to accelerate and improve clinical
decision making and patient outcomes."
EBM is a long-term, problem-based learning process that involves:
*Conversion of information needs into focused questions
*Identification of the best evidence for answering a question
*Review of evidence for validity and clinical usefulness
*Application of results to clinical practice
*Evaluation of how the evidence performs in clinical applications
Identified within this brief are opportunities and strategies that will assist
the healthcare system through the EMB journey such as:
*The U.S. faces a serious shortage of primary care clinicians with an
estimated increase in the advanced practice clinician workforce by 15
percent within the year; solutions - many involving technologies like
clinician insight engines - are already in sight for many practices.
*EBM can go a long way in reducing healthcare's failure to implement
preventive and patient safety best practices, which typically result in
injuries, negative patient outcomes and runaway costs. It can also
minimize the burden of overtreatment, where physicians' habits and
preferences sometimes trump medical evidence.
*In an environment where operating costs continue to collide with declining
reimbursement, HCOs struggle to maintain revenue, manage overhead and
ensure quality, safety and efficiency. EBM will play a critical role in
helping healthcare leaders make informed, disciplined choices on a broad
array of challenges-from physician integration, hospital consolidation,
strategic alignments and new reimbursement models, to technology
optimization, risk mitigation, changing populations, and patient
Although EBM continues to evolve, it has already proven its capacity to
influence top-line healthcare issues. An analysis of EBM's potential impact on
healthcare's most pressing challenges, including clinician shortages, waste,
accountable care and patient engagement is also identified as an imperative
need within the healthcare system and further elaborated on in the issue
The issue brief is available for download at http://ckey.co/ckebmbiz .
Subsequent briefs will focus on EBM implementation and the future of EBM.
About Elsevier Elsevier is a world-leading provider of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet and Cell , and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier's
online solutions include ScienceDirect , Scopus , Reaxys , ClinicalKey and
Mosby's Suite , which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai's Pinpoint Review , which help
research and health care institutions deliver better outcomes more
cost-effectively. A global business headquartered in Amsterdam, Elsevier
employs 7,000 people worldwide. The company is part of Reed Elsevier Group
plc, a world leading provider of professional information solutions. The group
employs more than 30,000 people, including more than 15,000 in North America.
Reed Elsevier Group plc is owned equally by two parent companies, Reed
Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London,
Amsterdam and New York Stock Exchanges using the following ticker symbols:
London: REL; Amsterdam: REN; New York: RUK and ENL.
Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164
Press spacebar to pause and continue. Press esc to stop.